Literature DB >> 18398938

Intraarticular corticosteroid injections of the temporomandibular joint in juvenile idiopathic arthritis.

Sarah Ringold1, Troy R Torgerson, Mark A Egbert, Carol A Wallace.   

Abstract

OBJECTIVE: To describe the clinical and radiographic outcomes in a series of patients with juvenile idiopathic arthritis (JIA) who underwent one or more intraarticular corticosteroid (IAS) injections of the temporomandibular joint (TMJ) performed without imaging guidance.
METHODS: Retrospective chart review was performed for all patients with JIA diagnosed and treated at our institution between January 1, 2000, and January 1, 2006, who underwent one or more IAS injections of their TMJ. IAS injections were performed by the same oral and maxillofacial surgeon without imaging guidance, using either triamcinolone acetonide or triamcinolone hexacetonide. The primary outcomes assessed were maximal incisal opening (MIO) measurements, patient-reported symptoms, physical examination findings, and imaging results.
RESULTS: Twenty-five patients were identified. Twenty-one (84%) had radiographic evidence of TMJ disease when TMJ disease was first suspected by their physician. The 25 patients underwent 74 IAS injections on 47 separate occasions. When baseline MIO measurements were compared to the last MIO measurements of the study period, there was a mean increase in MIO of 6.9 mm (p = 0.002; 95% CI 3, 10.7). There was a mean increase in MIO of 3.8 mm following each IAS injection (p = 0.003; 95% CI 1.4, 6.2). Patients who underwent multiple IAS injections had a mean increase in MIO after first injection of 6.6 mm (p < 0.001; 95% CI 4.1, 9.1); however, the mean increase in MIO after subsequent injections was 0.4 mm (p = 0.8; 95% CI -3.5, 4.4). One patient developed subcutaneous atrophy at the injection site. Two patients developed small, asymptomatic intraarticular calcifications. No additional adverse events were reported.
CONCLUSIONS: In this patient population, there was an overall increase in MIO measurements following initial IAS injection and during the study period. Patients tended to have minimal response to subsequent injections. IAS injections performed without imaging guidance by an experienced oral and maxillofacial surgeon were well tolerated with only rare adverse events. The presence of radiographic changes when the physician first suspected TMJ disease in 84% of patients emphasizes the need for better screening and early intervention for synovitis in this joint.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18398938

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  13 in total

1.  Effectiveness of dexamethasone iontophoresis for temporomandibular joint involvement in juvenile idiopathic arthritis.

Authors:  Rina Mina; Paula Melson; Stephanie Powell; Marepalli Rao; Claas Hinze; Murray Passo; T Brent Graham; Hermine I Brunner
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

Review 2.  Emergence of Musculoskeletal Ultrasound Use in Pediatric Rheumatology.

Authors:  Johannes Roth
Journal:  Curr Rheumatol Rep       Date:  2020-04-14       Impact factor: 4.592

3.  Relationship between disease course in the temporomandibular joints and mandibular growth rotation in patients with juvenile idiopathic arthritis followed from childhood to adulthood.

Authors:  Mg Fjeld; Lz Arvidsson; H-J Smith; B Flatø; B Ogaard; Ta Larheim
Journal:  Pediatr Rheumatol Online J       Date:  2010-04-22       Impact factor: 3.054

Review 4.  Emerging intra-articular drug delivery systems for the temporomandibular joint.

Authors:  Paschalia M Mountziaris; Phillip R Kramer; Antonios G Mikos
Journal:  Methods       Date:  2008-10-01       Impact factor: 3.608

Review 5.  [Juvenile idiopathic arthritis: the silent killer of pediatric temporomandibular joints].

Authors:  N Tzaribachev; D Weber; M Horger
Journal:  Z Rheumatol       Date:  2010-03       Impact factor: 1.372

6.  Temporomandibular joint steroid injections in patients with juvenile idiopathic arthritis: an observational pilot study on the long-term effect on signs and symptoms.

Authors:  Peter Stoustrup; Kasper Dahl Kristensen; Annelise Küseler; Thomas Klit Pedersen; Troels Herlin
Journal:  Pediatr Rheumatol Online J       Date:  2015-12-21       Impact factor: 3.054

7.  The temporomandibular joint in juvenile idiopathic arthritis: frequently used and frequently arthritic.

Authors:  Sarah Ringold; Randy Q Cron
Journal:  Pediatr Rheumatol Online J       Date:  2009-05-29       Impact factor: 3.054

8.  Intra-articular vs. systemic administration of etanercept in antigen-induced arthritis in the temporomandibular joint. Part II: mandibular growth.

Authors:  Peter Stoustrup; Kasper D Kristensen; Annelise Küseler; Thomas K Pedersen; John Gelineck; Troels Herlin
Journal:  Pediatr Rheumatol Online J       Date:  2009-02-06       Impact factor: 3.054

9.  Results of a multinational survey regarding the diagnosis and treatment of temporomandibular joint involvement in juvenile idiopathic arthritis.

Authors:  Ivan Foeldvari; Nikolay Tzaribachev; Randy Q Cron
Journal:  Pediatr Rheumatol Online J       Date:  2014-01-25       Impact factor: 3.054

Review 10.  Temporomandibular joint arthritis in juvenile idiopathic arthritis, now what?

Authors:  Matthew L Stoll; Chung H Kau; Peter D Waite; Randy Q Cron
Journal:  Pediatr Rheumatol Online J       Date:  2018-04-25       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.